Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Gilead Sciences, Inc. (GILD), Interactive Brokers Group, Inc. (IBKR): Should You Bet on These High-Growth Stocks?

Gilead Sciences, Inc. (NASDAQ:GILD)Proponents of income investing may not like it, but there is nothing like a growth portfolio, portions of which can be sold at higher prices to rival the benefits of a dividend portfolio. Buying at lower prices is also an effective strategy for stocks such as Gilead Sciences, Inc. (NASDAQ:GILD), Oasis Petroleum Inc. (NYSE:OAS), and Interactive Brokers Group, Inc. (NASDAQ:IBKR) which offer excellent earnings potential. Here is a closer look at these companies.

Gilead Sciences, Inc. (NASDAQ:GILD) still going strong

Gilead Sciences, Inc. (NASDAQ:GILD) is a bio-pharmaceutical company that develops medicines for human immunodeficiency virus (HIV), liver diseases, such as hepatitis B and hepatitis C and cardiovascular and respiratory conditions. With a market capitalization of $37 billion, the stock is among the most heavily-traded securities, and thus it comes as something of a surprise that its price has doubled over the last 12 months.

This surge has been aided by strong earnings results and encouraging updates of its drug-development program. In its latest update, the company reported results from four phase III studies named Neutrino, Fission, Positron and Fusion. The studies used the drugs on patients suffering from various genotypes of the chronic hepatitis C virus.

In the quarter ended Dec. 31, the company reported a 17.7% jump in revenue but it was the surge in net profit from $665 million to $762.5 million which made the market players buy this stock aggressively.

It has advanced 37% so far in 2013 and still trades at a forward price-to-earnings ratio of 17.6. Strong earnings visibility and a simplified capital structure are some of the factors that make analysts rate the stock as ‘Buy’ or ‘Outperform.’

Oil – Down but not out

Another attractive area to look for bargains is oil and gas exploration and production where stocks have lately taken a beating following the drop in crude-oil prices. Texas-based Oasis Petroleum Inc. (NYSE:OAS) is an exploration and production company focused on shale resources in the Montana and North Dakota regions of the Williston Basin.

The stock has dropped 11% over the month and now trades at attractive earnings multiples of 21 and 10.6 on a trailing 12-months and forward basis, respectively.

The forward-earnings multiple of 10.6 may not be foolproof, as this is evidently based on high oil-price expectations, but a low debt-to-equity ratio of 1.5 (going by the standards in the sector) offers some cushion to future earnings. This capital structure appears simple considering the fact that the company has grown its top line from $37 million in 2009 to $686.7 million in 2012. Profits have also grown in a linear fashion, and so far its trajectory looks uninterrupted.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.